Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intestinal Neoplasm”

10,108 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 10,108 results

Early research (Phase 1)WithdrawnNCT04500548
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study

Who this might be right for
Constitutional Mismatch Repair Deficiency SyndromeHematopoietic and Lymphoid Cell NeoplasmLynch Syndrome+9 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT03087591
What this trial is testing

APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Solid NeoplasmRecurrent Colorectal Carcinoma+9 more
Wake Forest University Health Sciences 11
Not applicableLooking for participantsNCT06802991
What this trial is testing

Optimised Post-discharge Care in Older Patients After Surgery for Colon Cancer (ERAS 3.0)

Who this might be right for
Colon CancerFrailty
Copenhagen University Hospital at Herlev 60
Not applicableUnknownNCT02406118
What this trial is testing

Phase II Clinical Trial for the Evaluation of the Efficacy of Transanal TME

Who this might be right for
Rectal Cancer
National Cancer Center, Korea 49
Early research (Phase 1)Active Not RecruitingNCT06806046
What this trial is testing

Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Chinese Participants With Solid Tumors

Who this might be right for
Solid TumorsColorectal Cancer
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 12
Very early researchLooking for participantsNCT07167446
What this trial is testing

Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy

Who this might be right for
Oxaliplatin Induced Peripheral Neuropathy in Cancer PatientsMetastatic Colorectal Cancer (CRC)Peripheral Neuropathy Due to Chemotherapy
Fox Chase Cancer Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07527520
What this trial is testing

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial

Who this might be right for
Rectal CancerModerately Hypofractionated RadiotherapySerplulimab+1 more
Fudan University 165
Very early researchEnded earlyNCT04906382
What this trial is testing

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Who this might be right for
Lynch SyndromeRecurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell Adenocarcinoma+4 more
Floor Backes, MD 2
Large-scale testing (Phase 3)UnknownNCT03909724
What this trial is testing

Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC)

Who this might be right for
Colorectal CancerMetastasis
Amsterdam UMC, location VUmc 60
Not applicableStudy completedNCT02054923
What this trial is testing

The Effect of Routine Video-recording on Colonoscopy Quality Indicators.

Who this might be right for
Colorectal Cancer
Maria Sklodowska-Curie National Research Institute of Oncology 5,200
Not applicableLooking for participantsNCT03941080
What this trial is testing

Gut Microbiome Dynamics in Metastasized or Irresectable Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
University Medical Center Groningen 300
Not applicableStudy completedNCT06549803
What this trial is testing

Comparison of Method for Skin Closure in Colorectal Cancer.

Who this might be right for
Surgical Site InfectionColorectal Cancer
Yoon Suk Lee 304
Testing effectiveness (Phase 2)Study completedNCT02040142
What this trial is testing

HIPEC for Peritoneal Carcinomatosis

Who this might be right for
Peritoneal CarcinomatosisColorectal CancerAppendiceal Cancer+3 more
Albert Einstein College of Medicine 51
Not applicableStudy completedNCT02593591
What this trial is testing

Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.

Who this might be right for
Colorectal Cancer
Samsung Medical Center 40
Not applicableUnknownNCT03218423
What this trial is testing

Longitudinal Performance of Epi proColon

Who this might be right for
Colorectal CancerColorectal Neoplasms
Epigenomics, Inc 4,500
Early research (Phase 1)UnknownNCT00016042
What this trial is testing

Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer

Who this might be right for
Colorectal CancerKidney Cancer
St. Luke's Medical Center
Not applicableLooking for participantsNCT04751435
What this trial is testing

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

Who this might be right for
Educational Materials for Genetic TestingBreast CancerOvarian Cancer+3 more
Memorial Sloan Kettering Cancer Center 445
Testing effectiveness (Phase 2)WithdrawnNCT00954876
What this trial is testing

Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Translational Genomics Research Institute
Testing effectiveness (Phase 2)Study completedNCT02469480
What this trial is testing

Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.

Who this might be right for
Metastatic Colorectal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 64
Testing effectiveness (Phase 2)UnknownNCT01826396
What this trial is testing

Standard and High Dose Irinotecan Based on UGT1A1 Genotype for First-line Treatment of Locally Advanced Colon Cancer

Who this might be right for
Colonic Neoplasms
Colorectal Cancer Institute of the Heilongjiang Academy of Medical Sciences 100
Load More Results